Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): School-Based Adolescent Vaccination, Funding Opportunity Announcement (FOA) IP08-006 and School-Based Influenza Vaccine, FOA IP08-007, 22418 [E8-9054]
Download as PDF
<![CDATA[
22418
Federal Register / Vol. 73, No. 81 / Friday, April 25, 2008 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): School-Based
Adolescent Vaccination, Funding
Opportunity Announcement (FOA)
IP08–006 and School-Based Influenza
Vaccine, FOA IP08–007
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 12 p.m.–5 p.m., May 22,
2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘School-Based Adolescent
Vaccination, FOA IP08–006 and SchoolBased Influenza Vaccine, FOA IP08–007.’’
Contact Person for More Information:
Maurine Goodman, M.A., M.P.H., Scientific
Review Administrator, Office of the Director,
Office of the Chief Science Officer, CDC,
1600 Clifton Road, NE., Mailstop D72,
Atlanta, GA 30333, Telephone: (404) 639–
4737.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 21, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–9054 Filed 4–24–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
sroberts on PROD1PC70 with NOTICES
[Document Identifier: CMS–1771, CMS–
10145, CMS–10204 and CMS–10255]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Department of
Health and Human Services.
AGENCY:
VerDate Aug<31>2005
20:20 Apr 24, 2008
Jkt 214001
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Attending
Physicians Statement and
Documentation of Medicare Emergency
and Supporting Regulations in 42 CFR
424.103; Use: 42 CFR 424.103(b)
requires that before a nonparticipating
hospital may be paid for emergency
services rendered to a Medicare
beneficiary, a statement must be
submitted that is sufficiently
comprehensive to support that an
emergency existed. Form CMS–1771
contains a series of questions relating to
the medical necessity of the emergency.
The attending physician must attest that
the hospitalization was required under
the regulatory emergency definition (42
CFR 424.101) and give clinical
documentation to support the claim.
Form Number: CMS–1771 (OMB# 0938–
0023); Frequency: Yearly; Affected
Public: Private sector—business or other
for-profit and not-for-profit institutions;
Number of Respondents: 100; Total
Annual Responses: 200; Total Annual
Hours: 50.
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare Part B
Drug and Biological Competitive
Acquisition Program and Supporting
Regulations in 42 CFR Sections 414.906,
414.908, 414.910, 414.914, 414.916, and
414.917; Use: Section 303(d) of the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA) provides an alternative
payment methodology for Part B
covered drugs that are not paid on a cost
or prospective payment basis. In
particular, Section 303(d) of the MMA
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
amends Title XVIII of the Social
Security Act by adding a new section
1847(B), which establishes a
competitive acquisition program for the
acquisition of and payment for Part B
covered drugs and biologicals furnished
on or after January 1, 2006. Since its
inception, additional legislation has
augmented the CAP. Section 108 of the
Medicare Improvements and Extension
Act under Division B, Title I of the Tax
Relief Health Care Act of 2006 (MIEA–
TRHCA) amended Section 1847b(a)(3)
of the Social Security Act and requires
that CAP implement a post payment
review process. This procedure is done
to assure that payment is made for a
drug or biological under this section
only if the drug or biological has been
administered to a beneficiary. Form
Number: CMS–10145 (OMB# 0938–
0945); Frequency: Weekly; Affected
Public: Private sector—business or other
for-profit and not-for-profit institutions;
Number of Respondents: 3000; Total
Annual Responses: 156,000; Total
Annual Hours: 31,188.
3. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Evaluation of
the Medical Adult Day Care Services
Demonstration; Use: Section 703 of the
Medicare Prescription Drug,
Improvement and Modernization Act of
2003 (Pub. L. 108–173) authorizes a
three-year demonstration to conduct an
evaluation of the clinical and costeffectiveness of providing medical adult
day-care services as a substitute for a
portion of home health services that
would otherwise be provided in the
beneficiary’s home. Delivering home
health services in the adult day-care
setting represents an expansion of
coverage under the home health benefit
under Medicare. The Demonstration
aims to evaluate both the costs and the
benefits of delivering home health
services in the adult day-care setting.
The evaluation will examine the
achievements as well as the difficulties
inherent in demonstration
implementation.
Telephone survey data from Medicare
beneficiary’s interviews are to be
completed during Phase II of the
Evaluation of the Medical Adult DayCare Services Demonstration. The
survey was developed based on
collection of data from face-to-face
interviews with beneficiaries from
Phase I of the Demonstration evaluation.
Form Number: CMS–10204 (OMB#
0938–1017); Frequency: Once; Affected
Public: Individuals or households;
Number of Respondents: 900; Total
Annual Responses: 900; Total Annual
Hours: 150.
E:\FR\FM\25APN1.SGM
25APN1
]]>Agencies
[Federal Register Volume 73, Number 81 (Friday, April 25, 2008)]
[Notices]
[Page 22418]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-9054]
[[Page 22418]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): School-Based Adolescent Vaccination, Funding
Opportunity Announcement (FOA) IP08-006 and School-Based Influenza
Vaccine, FOA IP08-007
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
Time and Date: 12 p.m.-5 p.m., May 22, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of ``School-Based Adolescent Vaccination,
FOA IP08-006 and School-Based Influenza Vaccine, FOA IP08-007.''
Contact Person for More Information: Maurine Goodman, M.A.,
M.P.H., Scientific Review Administrator, Office of the Director,
Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE.,
Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639-4737.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: April 21, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-9054 Filed 4-24-08; 8:45 am]
BILLING CODE 4163-18-P
